PB2044: FINAL PATIENT‐REPORTED OUTCOMES FROM A PHASE 2, RANDOMISED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA
Hartford, Christopher, Nguyen, Quang P., Sherman, Steven, Pavani, Rodrigo, Aurand, Lisa, Rofail, Diana, Kelly, Richard
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P782: A PHASE 2, RANDOMIZED TRIAL EVALUATING THE SAFETY AND EFFICACY OF POZELIMAB AND CEMDISIRAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Jang, Jun‐Ho, Wong, Raymond, Pavani, Rodrigo, Aurand, Lisa, Nguyen, Quang P., Perlee, Lorah, Souttou, Amal, Weyne, Jonathan, Kelly, Richard
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
P797: A PHASE 2, OPEN‐LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF COMBINATION POZELIMAB AND CEMDISIRAN THERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA WHO SWITCH FROM ECULIZUMAB
Kelly, Richard, Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Senk, Brian, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Patient-Reported Outcomes from a Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria
Hartford, Chris, Dain, Bradley, Sherman, Steven, Zhang, Yi, Pavani, Rodrigo, Aurand, Lisa, Rofail, Diana, Kelly, Richard
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
19 Patient-reported outcomes from a phase 2, randomised trial evaluating the safety and efficacy of pozelimab and cemdisiran in patients with paroxysmal nocturnal haemoglobinuria
Hartford, Christopher, Nguyen, Quang P., Sherman, Steven, Pavani, Rodrigo, Aurand, Lisa, Rofail, Diana, Kelly, Richard J.
Published in Immunobiology (1979) (01.09.2023)
Published in Immunobiology (1979) (01.09.2023)
Get full text
Journal Article
A Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria
Jang, Jun Ho, Wong, Raymond, Pavani, Rodrigo, Aurand, Lisa, Dain, Bradley, Perlee, Lorah, Souttou, Amal, Weyne, Jonathan, Kelly, Richard
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
52-Week Open-Label Extension Data from a Phase 2 Study Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran Combination Therapy in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Switched from Eculizumab
Kelly, Richard J., Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Mohan, Kosalai, Senk, Brian, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
A Phase 2, Open-Label Study Evaluating the Safety and Efficacy of Combination Pozelimab and Cemdisiran Therapy in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Switch from Eculizumab
Kelly, Richard, Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Dain, Bradley, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
18 A phase 2, open-label study evaluating the safety and efficacy of combination pozelimab and cemdisiran therapy in patients with paroxysmal nocturnal hemoglobinuria who switch from eculizumab
Kelly, Richard J., Houghton, Nicola, Munir, Talha, Muus, Petra, Youngs, Nora, Aurand, Lisa, Senk, Brian, Pavani, Rodrigo, Perlee, Lorah, Souttou, Amal, Griffin, Morag
Published in Immunobiology (1979) (01.09.2023)
Published in Immunobiology (1979) (01.09.2023)
Get full text
Journal Article
17 A phase 2, randomized trial evaluating the safety and efficacy of Pozelimab and Cemdisiran in patients with paroxysmal nocturnal hemoglobinuria
Jang, Jun-Ho, Wong, Raymond, Pavani, Rodrigo, Aurand, Lisa, Nguyen, Quang P., Perlee, Lorah, Souttou, Amal, Weyne, Jonathan, Kelly, Richard J.
Published in Immunobiology (1979) (01.09.2023)
Published in Immunobiology (1979) (01.09.2023)
Get full text
Journal Article
Transfusion Requirements in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria with or without a History of Bone Marrow Disorder Receiving Ravulizumab and Eculizumab: Results from a Phase 3 Non-Inferiority Study Extension
Risitano, Antonio, Jang, Jun-Ho, Gyeong-Won, Lee, Wanachiwanawin, Wanchai, Schrezenmeier, Hubert, Yonemura, Yuji, Munir, Talha, Pavani, Rodrigo, Wang, Jimmy, Kulagin, Alexander D., Kulasekararaj, Austin, Sicre de Fontbrune, Flore, Röth, Alexander
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Breakthrough Hemolysis in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies
Hill, Anita, Piatek, Caroline I., Peffault de Latour, Régis, Wong, Lily LL, Wells, Richard A., Brodsky, Robert A., Kim, Jin Seok, Nishimura, Junichi, Kuriakose, Philip, Pavani, Rodrigo, Liu, Peng, Ortiz, Stephan, Schrezenmeier, Hubert, Lee, Jong-Wook, Kulasekararaj, Austin
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article